Eye Movement Desensitization and Reprocessing (EMDR) to Treat Chronic Pruritus

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity Hospital, Basel, Switzerland

About this trial

Pruritus is a common symptom of numerous dermatological and non-dermatological conditions. Current treatments for chronic pruritus (CP) are often not fully effective and may have burdensome side effects. Recently, the trauma exposure technique Eye Movement Desensitization and Reprocessing (EMDR) that is recommended as first line treatment for posttraumatic stress disorder has been reported to be also effective in the treatment of CP in anecdotal clinical case observations. However, to the best of the investigator's knowledge, the efficacy of EMDR in CP has not yet been systematically explored. This study aims at addressing this unmet need in a prospective pilot study comparing EMDR versus treatment as usual (TAU).

Eligibility criteria

Qualifiers

Provided written informed consent

Age 18 to 75 years

Skindex-29 (questionnaire) symptoms subscale ≥42

Confirmed diagnosis CP

Disqualifiers

Inability to follow the procedures of the study, e.g. due to language problems, severe psychiatric disorders such as delusional disorder, suicidality or dementia.

Patients on phototherapy

Acute attacks of an autoimmune disease such as Crohn's disease

Serious cardiac disease

Trial design

Treatments tested in this trial

  • Eye Movement Desensitization and Reprocessing

Treatment groups

30 Participants
are divided into 2 treatment groups